Alimera Sciences Investor Relations Material
Latest events
Q1 2024
Alimera Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alimera Sciences Inc
Access all reports
Alimera Sciences Inc. is a pharmaceutical company focused on the development and commercialization of prescription ophthalmic treatments. The company specializes in therapies for retinal diseases, aiming to improve vision and quality of life for patients. The company is headquartered in Alpharetta, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ALIM
Country
🇺🇸 United States